Signature Wealth Management Partners’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Signature Wealth Management Partners’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-15,556	Closed	-$152K	–	114
2021 Q3	$152K	Sell	15,556 -12,155	-44%	-$114K	0.14%	105
2021 Q2	$274K	Sell	27,711 -12,491	-31%	-$132K	0.25%	88
2021 Q1	$464K	Buy	40,202 +22,811	+131%	+$262K	0.45%	59
2020 Q4	$168K	Buy	+17,391	New	+$167K	0.17%	91

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Signature Wealth Management Partners's TEVA Position: Q4 2021 in Review

Signature Wealth Management Partners sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2021, closing a stake of 15,556 shares — an estimated $152K sold.

Signature Wealth Management Partners first reported a position in TEVA in Q4 2020 and held it in 4 quarters. The position peaked at $464K in Q1 2021. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2021.

Signature Wealth Management Partners reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2021 after selling out during the quarter.
Signature Wealth Management Partners sold 15,556 Teva Pharmaceutical Industries Limited shares in Q4 2021, an estimated $152K.
Signature Wealth Management Partners first reported a position in Teva Pharmaceutical Industries Limited in Q4 2020 and held it in 4 quarters.
Signature Wealth Management Partners's Teva Pharmaceutical Industries Limited position peaked at $464K in Q1 2021.
450 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2021.

Based on Signature Wealth Management Partners's 13F filing for Q4 2021, filed 19 Jan 2022.